Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood-Brain Barrier | 17 | 2023 | 153 | 6.240 |
Why?
|
| Alzheimer Disease | 20 | 2023 | 881 | 4.680 |
Why?
|
| Peptide Fragments | 11 | 2023 | 298 | 3.240 |
Why?
|
| Insulin | 5 | 2022 | 224 | 2.220 |
Why?
|
| Neurons | 6 | 2020 | 1130 | 1.560 |
Why?
|
| Brain | 10 | 2022 | 1268 | 1.540 |
Why?
|
| Endocytosis | 4 | 2019 | 104 | 1.450 |
Why?
|
| Nanoparticles | 4 | 2018 | 294 | 1.400 |
Why?
|
| Protein Transport | 7 | 2020 | 286 | 1.380 |
Why?
|
| Cerebral Amyloid Angiopathy | 4 | 2014 | 17 | 1.360 |
Why?
|
| Endothelial Cells | 4 | 2023 | 296 | 1.080 |
Why?
|
| Chitosan | 4 | 2013 | 36 | 1.050 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2018 | 468 | 0.970 |
Why?
|
| Endothelium | 5 | 2023 | 31 | 0.880 |
Why?
|
| Animals | 26 | 2022 | 14307 | 0.840 |
Why?
|
| Mice | 17 | 2022 | 5668 | 0.750 |
Why?
|
| Vesicle-Associated Membrane Protein 2 | 1 | 2020 | 2 | 0.750 |
Why?
|
| Synaptosomal-Associated Protein 25 | 1 | 2020 | 8 | 0.740 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2020 | 50 | 0.720 |
Why?
|
| Clathrin | 1 | 2019 | 19 | 0.700 |
Why?
|
| Apolipoprotein A-I | 1 | 2019 | 21 | 0.700 |
Why?
|
| Scopolamine | 1 | 2018 | 4 | 0.680 |
Why?
|
| Antiemetics | 1 | 2018 | 7 | 0.680 |
Why?
|
| Solid Phase Extraction | 1 | 2018 | 12 | 0.680 |
Why?
|
| Cholesterol | 1 | 2019 | 194 | 0.630 |
Why?
|
| Peptides | 1 | 2020 | 308 | 0.620 |
Why?
|
| Cell Line | 5 | 2021 | 1289 | 0.610 |
Why?
|
| Humans | 26 | 2023 | 34853 | 0.610 |
Why?
|
| Brain Chemistry | 1 | 2017 | 134 | 0.600 |
Why?
|
| Aging | 1 | 2022 | 639 | 0.600 |
Why?
|
| Drug Carriers | 2 | 2010 | 121 | 0.580 |
Why?
|
| PC12 Cells | 5 | 2018 | 84 | 0.550 |
Why?
|
| Olfactory Mucosa | 2 | 2005 | 17 | 0.540 |
Why?
|
| Rats | 7 | 2019 | 3261 | 0.490 |
Why?
|
| Acrylic Resins | 1 | 2013 | 7 | 0.470 |
Why?
|
| Vaginosis, Bacterial | 1 | 2013 | 6 | 0.470 |
Why?
|
| Gels | 1 | 2013 | 41 | 0.460 |
Why?
|
| Mice, Transgenic | 8 | 2022 | 608 | 0.450 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2013 | 57 | 0.440 |
Why?
|
| Drug Delivery Systems | 1 | 2014 | 182 | 0.430 |
Why?
|
| Amyloid | 2 | 2012 | 52 | 0.430 |
Why?
|
| Nanostructures | 1 | 2014 | 133 | 0.430 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2011 | 14 | 0.410 |
Why?
|
| Biofilms | 1 | 2013 | 166 | 0.400 |
Why?
|
| Cerebral Cortex | 2 | 2010 | 274 | 0.380 |
Why?
|
| Cattle | 5 | 2013 | 472 | 0.370 |
Why?
|
| Fatty Alcohols | 1 | 2010 | 7 | 0.370 |
Why?
|
| Skin Absorption | 1 | 2010 | 12 | 0.370 |
Why?
|
| Contrast Media | 2 | 2008 | 95 | 0.370 |
Why?
|
| Melatonin | 1 | 2010 | 78 | 0.350 |
Why?
|
| Hippocampus | 2 | 2010 | 546 | 0.340 |
Why?
|
| Chlorpheniramine | 2 | 2005 | 2 | 0.340 |
Why?
|
| Skin | 1 | 2010 | 173 | 0.340 |
Why?
|
| Mutation | 2 | 2012 | 1023 | 0.320 |
Why?
|
| Permeability | 3 | 2019 | 67 | 0.310 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 1300 | 0.300 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 229 | 0.300 |
Why?
|
| Lysosomes | 3 | 2019 | 80 | 0.300 |
Why?
|
| Putrescine | 1 | 2006 | 25 | 0.290 |
Why?
|
| Iodine Radioisotopes | 2 | 2022 | 33 | 0.280 |
Why?
|
| Triprolidine | 1 | 2005 | 1 | 0.280 |
Why?
|
| Hydroxyzine | 1 | 2005 | 2 | 0.280 |
Why?
|
| Kinetics | 3 | 2020 | 650 | 0.260 |
Why?
|
| Administration, Cutaneous | 2 | 2018 | 38 | 0.260 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2014 | 16 | 0.250 |
Why?
|
| Piperazines | 1 | 2005 | 109 | 0.250 |
Why?
|
| Virus Internalization | 1 | 2023 | 27 | 0.230 |
Why?
|
| Protein Isoforms | 1 | 2023 | 121 | 0.230 |
Why?
|
| Models, Biological | 2 | 2020 | 642 | 0.220 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2018 | 406 | 0.220 |
Why?
|
| Signal Transduction | 3 | 2022 | 1802 | 0.220 |
Why?
|
| Soybean Oil | 1 | 2022 | 3 | 0.220 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2022 | 34 | 0.220 |
Why?
|
| Gadolinium | 2 | 2014 | 27 | 0.200 |
Why?
|
| Cell Line, Tumor | 3 | 2020 | 2128 | 0.200 |
Why?
|
| Biological Transport | 3 | 2005 | 175 | 0.190 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 1534 | 0.190 |
Why?
|
| Insulin Resistance | 1 | 2022 | 177 | 0.190 |
Why?
|
| Injections, Intravenous | 2 | 2018 | 58 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2022 | 245 | 0.190 |
Why?
|
| Surface Plasmon Resonance | 2 | 2010 | 20 | 0.180 |
Why?
|
| Cells, Cultured | 3 | 2019 | 1442 | 0.180 |
Why?
|
| Protein Binding | 3 | 2020 | 913 | 0.180 |
Why?
|
| Receptor, Insulin | 1 | 2019 | 22 | 0.180 |
Why?
|
| Microscopy, Fluorescence | 1 | 2020 | 240 | 0.170 |
Why?
|
| Age Factors | 1 | 2022 | 1007 | 0.170 |
Why?
|
| Cross-Over Studies | 1 | 2018 | 102 | 0.160 |
Why?
|
| Amino Acid Sequence | 2 | 2012 | 1124 | 0.160 |
Why?
|
| Dogs | 1 | 2018 | 138 | 0.160 |
Why?
|
| Diffusion | 2 | 2010 | 49 | 0.160 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 1490 | 0.160 |
Why?
|
| Solubility | 2 | 2010 | 115 | 0.160 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 173 | 0.150 |
Why?
|
| Tissue Distribution | 1 | 2017 | 197 | 0.150 |
Why?
|
| Presenilin-1 | 2 | 2007 | 27 | 0.140 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2007 | 95 | 0.140 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 901 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2010 | 984 | 0.130 |
Why?
|
| Male | 4 | 2019 | 18870 | 0.130 |
Why?
|
| Gene Expression | 1 | 2017 | 639 | 0.130 |
Why?
|
| Cyclophosphamide | 1 | 2014 | 52 | 0.120 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 72 | 0.120 |
Why?
|
| Adhesives | 1 | 2013 | 3 | 0.120 |
Why?
|
| Cerebral Amyloid Angiopathy, Familial | 1 | 2013 | 3 | 0.120 |
Why?
|
| Pseudomonas Infections | 1 | 2013 | 18 | 0.120 |
Why?
|
| Female | 5 | 2019 | 19873 | 0.120 |
Why?
|
| Mutant Proteins | 1 | 2013 | 48 | 0.110 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2012 | 16 | 0.110 |
Why?
|
| Caveolin 1 | 1 | 2012 | 27 | 0.110 |
Why?
|
| Endosomes | 1 | 2012 | 34 | 0.110 |
Why?
|
| Histidine | 1 | 2012 | 36 | 0.110 |
Why?
|
| Fluorescence Polarization | 1 | 2012 | 27 | 0.110 |
Why?
|
| Microscopy, Atomic Force | 1 | 2012 | 59 | 0.110 |
Why?
|
| Models, Neurological | 1 | 2013 | 123 | 0.110 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 143 | 0.100 |
Why?
|
| Drug Discovery | 1 | 2012 | 77 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 383 | 0.100 |
Why?
|
| Immunoglobulin Fragments | 2 | 2008 | 7 | 0.100 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 53 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 2 | 2009 | 282 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 1530 | 0.090 |
Why?
|
| Chemical Phenomena | 1 | 2010 | 53 | 0.090 |
Why?
|
| Inflammation | 1 | 2014 | 577 | 0.090 |
Why?
|
| Cell Compartmentation | 1 | 2009 | 12 | 0.090 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2010 | 196 | 0.090 |
Why?
|
| Heterocyclic Compounds | 1 | 2008 | 21 | 0.080 |
Why?
|
| Polyamines | 1 | 2008 | 28 | 0.080 |
Why?
|
| Adenosine Triphosphate | 1 | 2009 | 180 | 0.080 |
Why?
|
| Organometallic Compounds | 1 | 2008 | 68 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 117 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 1426 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2007 | 91 | 0.070 |
Why?
|
| Etoposide | 1 | 2005 | 21 | 0.070 |
Why?
|
| Motor Cortex | 1 | 2005 | 20 | 0.070 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2005 | 45 | 0.070 |
Why?
|
| Nasal Mucosa | 1 | 2005 | 29 | 0.070 |
Why?
|
| Motor Neurons | 1 | 2005 | 72 | 0.060 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 93 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2005 | 342 | 0.060 |
Why?
|
| Molecular Structure | 1 | 2005 | 467 | 0.060 |
Why?
|
| Adult | 1 | 2018 | 11034 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2005 | 486 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2005 | 874 | 0.040 |
Why?
|
| Swine | 1 | 2019 | 182 | 0.040 |
Why?
|
| Autophagy | 1 | 2019 | 111 | 0.040 |
Why?
|
| Proteobacteria | 1 | 2017 | 7 | 0.040 |
Why?
|
| Apoptosis | 1 | 2005 | 1317 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2008 | 195 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2017 | 165 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 104 | 0.040 |
Why?
|
| Immunoglobulin G | 2 | 2008 | 232 | 0.040 |
Why?
|
| Epitope Mapping | 1 | 2009 | 31 | 0.020 |
Why?
|
| Chromatography, Paper | 1 | 2008 | 1 | 0.020 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2008 | 12 | 0.020 |
Why?
|
| Isoelectric Focusing | 1 | 2007 | 16 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 2007 | 61 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 2007 | 33 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2007 | 103 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 859 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2007 | 59 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 445 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 1 | 2005 | 13 | 0.020 |
Why?
|
| MAP Kinase Kinase 3 | 1 | 2005 | 3 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2005 | 73 | 0.020 |
Why?
|
| Caspases | 1 | 2005 | 132 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2005 | 194 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2005 | 149 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2005 | 423 | 0.020 |
Why?
|
| Disease Progression | 1 | 2005 | 580 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2005 | 490 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2005 | 878 | 0.010 |
Why?
|